Health and care · Healthcare site. This page brings together reports naming this recipient and response statements clearly connected to concerns raised in those reports.
Reports
1
Naming this recipient
Published responses
100%
Found for named reports
Concerns addressed
2
Across all linked responses
Stated actions
8
Described in responses
Reports over time
Reports over time
Reports naming this recipient by issue year.
Evidence profile
Report topics
Share of this recipient’s reports compared with all other recipients.
100%published responses found
8stated actions described
Topic comparisons are not available in the current evidence snapshot.
Concerns and recipient responses
Statements from Fremington Medical Centre linked to the concerns in each report. Select any concern, action or position to view the source wording.
Exeter and Greater Devon
Concerns raised2
Failure to review patients receiving extended-term medication for suitability of continued long-term use
Failure to prescribe longer-acting rather than shorter-acting benzodiazepines for long-term use
Responses linked to these concerns
Each statement is shown once, even when linked to more than one concern.
Actions described in response An action is something this recipient says it has done, is doing, or plans to do in response to the concern raised.4
Action
Audit patients prescribed Lorazepam and all practice patients receiving it on repeat prescription.
Stated completedThe respondent said that this action was complete when they made their response on 3 December 2017.
Action
Send personal letters asking patients with repeat benzodiazepine prescriptions to arrange targeted medication reviews.
Stated completedThe respondent said that this action was complete when they made their response on 3 December 2017.
Action
Remind prescribing staff to discuss short-term benzodiazepine use, conduct regular reviews, and avoid adding these medicines to repeat prescriptions.
Stated completedThe respondent said that this action was complete when they made their response on 3 December 2017.
Action
Change future prescribing practice regarding switching short-acting benzodiazepines to longer-acting alternatives.
Stated plannedThe respondent said that this action was planned when they made their response on 3 December 2017.
Respondent positions A position is what this recipient says about the concern when it does not describe a specific action.1
Position
Switching to a long-acting benzodiazepine was not considered warranted in this case because clinical indications outweighed the risks.
Disputes the concernThe respondent disagreed with part of the concern or the basis for it.